Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Children's Autism Metabolome Project (CAMP): Development and Clinical Evaluation of the Stemina Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood

NCT02548442 is registered in ClinicalTrials.gov with Stemina Biomarker Discovery, Inc. as lead sponsor.

NCT NCT02548442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02548442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Children's Autism Metabolome Project (CAMP): Development and Clinical Evaluation of the Stemina Metabolic Biomarker-Based Test to Diagnose Autism Spectrum Disorder in Early Childhood
Lead sponsor
Stemina Biomarker Discovery, Inc.
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2015
Completion date
August 31, 2023
Enrollment
1,102 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder, developmental disorder